Jiande D. Han

No. 58, Zhongshan 2nd Road
Guangzhou, 510080, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Microbial Dysbiosis in Photodermatoses: Formation, Pathogenesis and Intervention Strategies.

Microbial Dysbiosis in Photodermatoses: Formation, Pathogenesis and Intervention Strategies.

Journal: Current issues in molecular biology

Published: April 14, 2026

Clinical characteristics associated with severe misdiagnosis of scabies: a retrospective hospital-based study.

Clinical characteristics associated with severe misdiagnosis of scabies: a retrospective hospital-based study.

Journal: BMC infectious diseases

Published: March 30, 2026

RASA2 Promotes Pancreatic Cancer Metastasis by Activating TGFβ-Dependent Non-canonical Hedgehog Signaling.

RASA2 Promotes Pancreatic Cancer Metastasis by Activating TGFβ-Dependent Non-canonical Hedgehog Signaling.

Journal: Cancer research

Published: January 22, 2026

Extended treatment of abrocitinib: evaluation of efficacy and safety in chronic actinic dermatitis.

Extended treatment of abrocitinib: evaluation of efficacy and safety in chronic actinic dermatitis.

Journal: Frontiers in medicine

Published: November 08, 2025

52-week ivarmacitinib in moderate-to-severe atopic dermatitis: A phase 3 trial.

52-week ivarmacitinib in moderate-to-severe atopic dermatitis: A phase 3 trial.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: October 28, 2025

Anti-interferon-γ Autoantibody-mediated Adult-onset Immunodeficiency with Disseminated Mycobacterium abscessus Complex Infection: A Report of Three Cases.

Anti-interferon-γ Autoantibody-mediated Adult-onset Immunodeficiency with Disseminated Mycobacterium abscessus Complex Infection: A Report of Three Cases.

Journal: International journal of mycobacteriology

Published: October 12, 2025

Ivarmacitinib ointment in treatment of adults with mild-to-moderate atopic dermatitis: phase III of a randomized double-blind placebo-controlled phase II/III clinical trial.

Ivarmacitinib ointment in treatment of adults with mild-to-moderate atopic dermatitis: phase III of a randomized double-blind placebo-controlled phase II/III clinical trial.

Journal: The British journal of dermatology

Published: August 25, 2025

Pathomics Signature for Prognosis and CA19-9 Interception in Pancreatic Ductal Adenocarcinoma: A Real-Life, Multi-Center Study.

Pathomics Signature for Prognosis and CA19-9 Interception in Pancreatic Ductal Adenocarcinoma: A Real-Life, Multi-Center Study.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 19, 2025

Otomycosis in Southern China: a retrospective analysis of clinical presentation, otoendoscopic features, and causative pathogens.

Otomycosis in Southern China: a retrospective analysis of clinical presentation, otoendoscopic features, and causative pathogens.

Journal: Mycopathologia

Published: August 09, 2025

Basophil activity in atopic dermatitis: Distinct immunomodulatory roles of dupilumab and abrocitinib.

Basophil activity in atopic dermatitis: Distinct immunomodulatory roles of dupilumab and abrocitinib.

Journal: The Journal of investigative dermatology

Published: July 28, 2025

Clinical Characteristics and Disease Course of Livedoid Vasculopathy: A 10-Year Retrospective Analysis.

Clinical Characteristics and Disease Course of Livedoid Vasculopathy: A 10-Year Retrospective Analysis.

Journal: Clinical, cosmetic and investigational dermatology

Published: July 08, 2025

Multiomics reveals CCL3-driving neuronal sensitization in chronic pruritus of unknown origin.

Multiomics reveals CCL3-driving neuronal sensitization in chronic pruritus of unknown origin.

Journal: The Journal of investigative dermatology

Published: May 03, 2025

Showing 1-12 of 54

Last Updated: 09/26/2026